What are the fundraising trends in the Pet Tech market?

Last updated: 13 July 2026
market research pitch 2026 statistics Pet Tech market

In our Pet Tech market deck, you will find everything you need to understand the market

SUMMARY

We analyzed publicly disclosed equity rounds raised by pure-play Pet Tech companies between January 2024 and July 2026, using a strict definition focused on software and connected devices that help people care for, monitor, train, and keep pets healthy and safe. The sample excludes pet food, general pet retail, offline-first clinics, insurance without a digital care layer, biotech/pharma-first animal health, debt, grants, acquisitions, undisclosed-size rounds, and rounds below $300K.

The Pet Tech market expanded sharply in the last completed year. Full-year funding rose from about $65M across 7 deals in 2024 to about $167M across 14 deals in 2025, which means 2025 delivered both more capital and more funded companies.

The freshest 2026 signal is much narrower. Between January and July 2026, the Pet Tech market raised about $91M across 4 qualifying deals, compared with about $101M across 9 deals over the comparable 2025 period. Headline capital is only slightly lower, but deal activity is much thinner.

YTD 2026 funding is heavily distorted by one company. Lassie’s $75M Series C accounts for roughly 82.5% of all YTD 2026 Pet Tech capital, so the current-year number should not be read as broad category strength.

Pet Care Apps have become the clear capital center of the Pet Tech market. The category captured about 53% of 2024 capital, about 81% of 2025 capital, and more than 95% of YTD 2026 capital, showing that investors increasingly prefer care, workflow, payments, insurance, pharmacy, diagnostics, and health-management software.

The Pet Tech market is not being funded as a consumer gadget cycle. Connected Pet Feeders and Pet Monitoring Cameras produced no qualifying disclosed equity rounds in 2024, 2025, or YTD 2026, while Smart Pet Devices and Pet Health Wearables only appeared when tied to AI, health monitoring, behavior interpretation, or data infrastructure.

Capital is moving toward proven companies. First financings represented about 43% of deals in 2024, about 29% in 2025, and 25% in YTD 2026, but their capital share stayed much lower, falling to only about 2% in YTD 2026.

Europe is gaining capital weight, but recent European dominance is distorted by Lassie. Europe captured about 37% of full-year 2025 capital and 82.5% of YTD 2026 capital, while North America still produced the most consistent deal flow across the full period.

The Pet Tech market has attracted serious investors, including Andreessen Horowitz, Base10, Balderton, Felix, Northzone, B Capital, First Round, Atomico, Partech, and others. But repeat-investor activity remains limited, which suggests that the market is not yet a deeply institutionalized specialist funding category.

The main interpretation is that Pet Tech is becoming a healthcare-adjacent software market rather than a broad pet gadget market. The strongest companies are turning pet-owner demand into recurring infrastructure around veterinary work, insurance, claims, payments, diagnostics, pharmacy, and preventive care.

Chart illustrating revenue distribution by customer segment in the pet tech market

This chart, featured in our Pet Tech market deck, illustrates revenue distribution by customer segment in the pet tech market

Is more or less capital going into the Pet Tech market?

More capital went into the Pet Tech market in the last completed year, but the freshest 2026 evidence is weaker once the single largest round is separated from the rest of the market. Full-year Pet Tech funding rose from about $65M in 2024 to about $167M in 2025, which is a strong increase, but January through July 2026 produced about $91M across only 4 deals versus about $101M across 9 deals over the comparable 2025 period.

The full-year comparison is the cleaner structural signal because it uses two complete calendar years. It says the Pet Tech market clearly expanded in 2025: deal count doubled, total capital rose sharply, median round size increased, and more investors appeared in the market.

The YTD 2026 comparison is fresher but more fragile. Lassie’s $75M Series C represents about 82.5% of all Pet Tech capital raised between January and July 2026, which means the headline total is mostly one scaled European digital pet insurance and care platform.

Without Lassie, YTD 2026 funding would be only about $16M. That makes the current-year signal much less bullish than the headline implies, because the broader market outside one winner has been relatively quiet.

The best reading is that the Pet Tech market had a real expansion year in 2025, followed by a much more selective 2026 funding environment. Capital has not disappeared, but broad-based deployment has weakened.

Is Pet Tech funding activity driven by more deals or larger rounds?

Pet Tech funding activity was driven by both more deals and larger rounds in full-year 2025, but YTD 2026 is driven almost entirely by one larger round. From 2024 to 2025, the number of deals doubled from 7 to 14, total capital rose from about $65M to about $167M, average round size increased from about $9M to about $12M, and median round size rose from about $4M to about $11M.

That full-year 2025 pattern matters because it was not just one outlier inflating the market. More Pet Tech companies raised funding, and the typical disclosed round became meaningfully larger.

The current-year picture is very different. Between January and July 2026, deal count fell to 4 from 9 over the comparable 2025 period, while the average round size rose to about $23M only because Lassie raised $75M.

The median YTD 2026 round was about $7M, below the roughly $11M median over the comparable 2025 period. That median is the more honest indicator of the typical Pet Tech financing, because the average is being pulled upward by one large Series C.

The practical takeaway is that 2025 expansion was broad, but 2026 funding is not. The current Pet Tech market is being held up by larger-round concentration rather than by a wider base of funded companies.

For deeper benchmarks on Pet Tech deal sizes, medians, and funding distribution, see the full Pet Tech market report.

Is Pet Tech capital moving toward later-stage or earlier-stage companies?

Pet Tech capital is moving toward later-stage companies by dollars, even though earlier-stage activity still exists by deal count. In 2025, Series B rounds captured about $92M, or roughly 55% of total Pet Tech capital, while Seed and Series A together captured about $56.5M, or roughly 34%.

The YTD 2026 stage mix makes the later-stage shift even more obvious. Lassie’s $75M Series C represented about 82.5% of all YTD Pet Tech capital, while the two Series A rounds and one unknown-stage round together represented only about 17.5%.

By deal count, the Pet Tech market still contains early and formation-stage companies. YTD 2026 had 2 Series A deals, 1 Series C deal, and 1 unknown-stage deal, so early-stage and unknown-stage companies represented most of the company activity.

But dollars are what reveal investor conviction. The large checks are going toward companies with stronger evidence of scale, recurring use, clinical or financial infrastructure, or proven pet-health economics.

The better interpretation is a barbell market. New Pet Tech ideas are still being tested with smaller checks, while the largest pools of capital are reserved for companies that already look like scaled platforms.

Chart comparing business model options for pet GPS wearable companies

This chart, included in our Pet Tech market deck, compares the main business model options for pet GPS wearable companies

Is the Pet Tech market maturing or still experimental?

The Pet Tech market is maturing around a narrow set of healthcare-adjacent software models, but it remains experimental across the broader gadget and consumer-app universe. The strongest funding signals now sit in Pet Care Apps, digital insurance, pet-care financing, veterinary workflow, pharmacy coordination, diagnostics, and AI-enabled care infrastructure.

The maturation signal is clearest in the 2024 to 2025 comparison. The Pet Tech market moved from 7 deals and about $65M in 2024 to 14 deals and about $167M in 2025, while the median round size rose from about $4M to about $11M.

Stage mix also points to maturation. Series B rounds captured about 55% of 2025 capital, and YTD 2026 funding was dominated by a Series C round, which means the largest checks are flowing to companies with more proof than seed-stage concepts.

But the Pet Tech market is not mature across all categories. Connected Pet Feeders and Pet Monitoring Cameras have produced no qualifying disclosed equity rounds across 2024, 2025, and YTD 2026, and standalone Tele Vet Platforms have no qualifying YTD 2026 deal.

So the Pet Tech market is not a fully mature, diversified venture category. It is becoming mature where software touches care economics, but it is still experimental or weakly funded where the product is a standalone consumer device or single-feature app.

Are new startups still entering the Pet Tech market?

Yes, new startups are still entering the Pet Tech market, but they are not receiving most of the capital. First financings represented about 43% of deals in 2024, about 29% of deals in 2025, and 25% of deals in YTD 2026, showing that formation has continued across the period.

The dollar share tells a more cautious story. First financings captured only about 16% of capital in 2024, about 17% in 2025, and just about 2% in YTD 2026.

That repeated gap means investors are willing to test new Pet Tech ideas, but they are not allocating the biggest checks to new entrants. The larger rounds are going to follow-on companies with evidence of adoption, repeat use, or stronger platform economics.

The new-company signal is also more selective than broad. Across the period, new entrants appeared in AI veterinary workflow, pet health-record connectivity, diagnostics, pet-care SaaS, financing, and digital care-management tools rather than in simple consumer hardware.

The Pet Tech market therefore still has startup formation, but it is not a formation-led funding cycle. New companies are entering the market through small checks, while the main dollars follow companies that already look validated.

For more context on new Pet Tech startups, first financings, and formation-stage activity, see the Pet Tech market deck.

Are more investors entering the Pet Tech market?

More investors entered the Pet Tech market in 2025, but the YTD 2026 window does not show continued broadening. The number of disclosed investors rose from about 26 in 2024 to about 47 in 2025, which is a meaningful expansion in investor participation.

The 2025 expansion was supported by more deals and a wider set of investor types. The Pet Tech market attracted venture firms, strategic investors, government-backed funds, specialist pet-health investors, and regional capital across North America, Europe, and Asia-Pacific.

The freshest 2026 signal is narrower. Between January and July 2026, only about 11 disclosed investors appeared across 4 qualifying deals, compared with roughly 29 disclosed investors across 9 deals over the comparable 2025 period.

That decline should be interpreted carefully because YTD 2026 has a small sample. Fewer deals naturally mean fewer investors, and one large Lassie round distorts the capital picture.

The strongest conclusion is that investor participation broadened materially in 2025, but 2026 has become more selective. The Pet Tech market is still attracting serious capital, but fewer investors are participating in the current funding window.

Chart showing the projected CAGR of the pet tech market

This chart, included in our Pet Tech market deck, shows annual funding in pet tech startups

Are top investors getting more or less active in Pet Tech?

Top investors are more visible in the Pet Tech market than they were in 2024, but they are not becoming repeat-active enough to prove a mature specialist investor ecosystem. High-quality investors appeared in 2024 through deals involving MoeGo, FirstVet, and Scribenote, and the roster broadened further in 2025 with names such as Balderton, Felix, Northzone, B Capital, First Round, firstminute, Atomico, Partech, Five Elms, and others.

Visibility is not the same as repeat activity. In 2024, Digitalis Ventures or the Digitalis Mars Companion Fund was the only investor appearing in more than one qualifying deal. In 2025, firstminute capital clearly appeared more than once through Lupa’s Seed and Series A rounds.

Through July 2026, no disclosed investor appeared in more than one qualifying Pet Tech deal. That weak repeat signal matters because repeat activity is usually what separates an emerging category from a fully institutionalized funding market.

The better interpretation is that top investors are making selective company-specific bets rather than building broad Pet Tech portfolios. A strong investor logo validates the individual company, but it does not yet validate the entire category.

The Pet Tech market is therefore credible but not deeply specialist-funded. Serious investors are present, but the market still lacks a tight group of repeat backers underwriting multiple companies every year.

Which Pet Tech subcategories are gaining momentum?

Pet Care Apps are the subcategory gaining the clearest momentum in the Pet Tech market. The category captured about $34M in 2024, about $135M in 2025, and about $87M in YTD 2026, increasing its capital share from roughly 53% to about 81% and then to more than 95%.

This is not just an app-store story. Pet Care Apps in this market include veterinary practice software, AI scribes, medical-record connectivity, digital insurance, claims automation, chronic medication delivery, preventive care financing, diagnostics, and daily care-management tools.

The hidden subcategory gaining the most momentum is digital pet healthcare finance. Lassie, Snout, Dalma, Napo, Pawchi, My Brown, Scooch, and Koala Health all point toward insurance, claims, payment plans, pharmacy, and recurring care economics as the strongest funding lane.

Pet Health Wearables have narrower momentum, but the pattern is real. Maven Pet raised in 2024, Traini raised in late 2025, and SATELLAI raised in early 2026, with each case relying on AI, health signals, behavior interpretation, or connected monitoring rather than basic tracking alone.

The strongest subcategory rule is that investors are funding Pet Tech when it becomes care infrastructure. The closer a company is to clinics, insurers, pharmacies, diagnostics, payments, or health data, the stronger the funding signal becomes.

For a fuller view of category momentum across Pet Care Apps, wearables, smart devices, tele-vet, feeders, and cameras, see the market report covering Pet Tech subcategories.

Which Pet Tech subcategories are losing momentum?

Connected Pet Feeders and Pet Monitoring Cameras are the clearest Pet Tech subcategories losing momentum, or more accurately failing to show venture momentum at all. Neither category produced a qualifying disclosed equity round above $300K in 2024, 2025, or YTD 2026 under the strict pure-play screen.

That repeated zero is meaningful because both categories are commercially visible to consumers. The absence of qualifying rounds suggests that venture investors may see these products as hardware-margin, ecommerce, incumbent-electronics, or bootstrapped-consumer categories rather than high-growth venture platforms.

Standalone Tele Vet Platforms also appear to be losing distinct momentum. Tele Vet Platforms captured about $22M in 2024 and $21M in 2025, but no qualifying standalone tele-vet round appeared in YTD 2026.

Tele-vet is not disappearing as a function. The more likely interpretation is that virtual vet access is becoming embedded inside insurance, diagnostics, employer benefits, pharmacy, and broader care-management platforms rather than funded as a standalone category.

Smart Pet Devices remain weak unless they connect to data or health infrastructure. The Pet Tech market is moving away from convenience hardware and toward systems that reduce care cost, labor burden, claims friction, or clinical uncertainty.

Chart showing Tractive’s strategy in the pet tech market

This chart, included in our Pet Tech market deck, looks at Tractive’s strategy in pet tech

Which regions are gaining momentum in Pet Tech funding?

Europe is gaining the most capital momentum in Pet Tech funding, especially in the freshest 2026 window. Europe captured about $26M in 2024, about $62M in 2025, and $75M in YTD 2026, with the current-year total driven by Lassie’s large Series C.

The 2026 European number should not be overread as balanced regional dominance. One company accounts for Europe’s entire YTD 2026 capital total, so the signal is more about a scaled winner than broad European deal flow.

Europe’s momentum is still real in the fuller comparison. In 2025, European Pet Tech companies such as Lupa, Napo, Dalma, and Scooch showed strong activity around digital insurance, veterinary workflow, AI care tools, and pet-health software.

North America remains highly relevant and consistent. It led full-year 2025 capital with about $85M and 6 deals, and it produced companies such as Goose, Tandem, Airvet, Koala Health, Digitail, Traini, Snout, and Petwealth across 2025 and YTD 2026.

Asia-Pacific is gaining modest formation momentum rather than capital momentum. APAC produced 2 deals in 2024, 3 deals in 2025, and 1 deal in YTD 2026, but its capital share stayed smaller than its deal share.

Which regions are losing momentum in Pet Tech funding?

North America is losing relative capital momentum in the freshest Pet Tech comparison, even though it remains one of the most important regions. Between January and July 2025, North America raised about $54M across 4 deals; between January and July 2026, it raised about $12M across 2 deals.

That drop is meaningful, but it should not be interpreted as a structural North American retreat. Full-year 2025 North America still led the Pet Tech market by capital, with about 51% of global funding and 43% of deal count.

Asia-Pacific is losing relative funding weight when measured by dollars. In 2025, APAC produced about 21% of deals but only about 12% of capital, and in YTD 2026 it produced 25% of deals but only about 5% of capital.

That means APAC remains visible but undercapitalized. The region continues to produce smart collar, pet insurance, and smart-device activity, but it has not yet produced the larger rounds seen in North America or Europe.

Latin America, the Middle East, and Africa remain absent under the strict public-source screen. That means no qualifying disclosed pure-play Pet Tech equity rounds above $300K surfaced from those regions across the reviewed funding windows.

Is the Pet Tech market becoming more global or more regionally concentrated?

The Pet Tech market is becoming more global by deal presence, but capital remains regionally concentrated around North America and Europe. In 2024 and 2025, qualifying Pet Tech deals appeared in North America, Europe, and Asia-Pacific, and the same three regions remain represented in YTD 2026.

The full-year 2025 comparison is the best evidence of geographic breadth. North America produced 6 deals, Europe produced 5 deals, and Asia-Pacific produced 3 deals, which shows that the Pet Tech market is not confined to one region.

The capital split is much less balanced. North America captured about 51% of 2025 capital, Europe captured about 37%, and Asia-Pacific captured about 12%.

In YTD 2026, the market looks far more regionally concentrated by dollars because Europe captured 82.5% of capital through one deal. By deal count, however, North America still produced half of all qualifying YTD 2026 deals.

The practical interpretation is that Pet Tech company formation is globalizing across three core regions, but scale capital is still concentrated in whichever region produces the largest proven platform in a given period. The market is geographically broader than it is financially balanced.

For ongoing regional tracking across North America, Europe, Asia-Pacific, and other regions, see the deeper analysis of the Pet Tech market.

Chart showing how pet humanization has driven growth in the pet tech market over time

This chart, included in our Pet Tech market deck, shows how pet humanization has driven growth in the pet tech market over time

Is Pet Tech capital moving toward proven winners or new opportunities?

Pet Tech capital is moving toward proven winners, while new opportunities continue to receive smaller exploratory checks. In 2024, first financings represented about 43% of deals but only about 16% of capital. In 2025, first financings represented about 29% of deals and about 17% of capital. In YTD 2026, first financings represented 25% of deals but only about 2% of capital.

That repeated gap between deal share and capital share is the clearest evidence that larger checks are going to follow-on companies. Investors are still funding new Pet Tech ideas, but not with the capital intensity reserved for validated platforms.

The same pattern appears in stage mix. Series B captured the largest share of 2025 capital, and Series C captured the overwhelming share of YTD 2026 capital.

Examples of proven-winner capital include companies such as Lassie, Digitail, Dalma, Koala Health, Napo, Airvet, FirstVet, MoeGo, and Snout. These companies sit near insurance, pharmacy, workflow, telehealth, financing, or recurring care systems rather than one-off consumer products.

The Pet Tech market is therefore becoming more proof-driven. New opportunities matter, but they need to show integration into pet healthcare economics before they can attract larger pools of capital.

Is the Pet Tech market becoming winner-takes-most?

The Pet Tech market became less winner-takes-most in full-year 2025, but YTD 2026 is strongly winner-takes-most because one company dominates capital. In 2024, the top 3 deals captured about 84% of total capital. In 2025, the top 3 deals captured about 39%, and the largest deal captured only about 14%.

That 2025 distribution was healthier because capital was spread across more companies. The median round size rose, deal count doubled, and no round exceeded $50M, which made the full-year funding environment less dependent on one outlier.

YTD 2026 reversed that pattern. Lassie alone captured about 82.5% of all capital, and the top 3 deals captured about 98%.

The largest-to-median ratio also jumped to about 10.6x in YTD 2026, compared with about 2.0x in full-year 2025. That ratio confirms that the current-year average is not representative of the typical Pet Tech company.

The strongest conclusion is that the Pet Tech market is highly vulnerable to winner-takes-most dynamics because the deal base is small. One scaled company can define the whole year’s funding narrative unless several mid-sized rounds appear across other categories.

Is the next wave of Pet Tech winners becoming visible?

Yes, the next wave of Pet Tech winners is becoming visible, but the likely winners are not mostly consumer hardware companies. The strongest emerging winners are building the operating, financial, and health infrastructure of pet care.

The full-year 2025 evidence is the clearest signal. Companies such as Digitail, Lupa, Dalma, Napo, Koala Health, Airvet, Goose, Tandem, and Pawchi all point toward veterinary workflow automation, digital insurance, pharmacy, employer or consumer care access, and pet-care operating systems.

The YTD 2026 evidence reinforces the same direction. Lassie and Snout attracted the largest capital pools because they connect to preventive care, claims, insurance, financing, and recurring pet-health engagement.

The visible next-wave themes are stronger than any single company list. Digital insurance, care financing, veterinary SaaS, AI documentation, diagnostics, pharmacy coordination, health-data capture, and preventive care are becoming the most investable areas.

The Pet Tech market is still too small to declare final winners. But investor selection is becoming clearer: companies that turn pet care into recurring infrastructure have a much stronger chance of scaling than standalone apps or gadgets.

For more context on emerging Pet Tech winners and the themes most likely to compound, see the full market view on Pet Tech winners.

Google Trends chart showing rising interest in pet cameras

As this chart shows, and as featured in our Pet Tech market deck, search interest in pet cameras has risen sharply

Is the Pet Tech funding landscape fragmenting or consolidating?

The Pet Tech funding landscape is thematically consolidating, even though the investor base and company base remain fragmented. Capital is consolidating around Pet Care Apps, which captured about 53% of 2024 capital, about 81% of 2025 capital, and more than 95% of YTD 2026 capital.

That category-level consolidation is extremely clear. Investors are converging on care-management software, insurance, claims, payments, diagnostics, pharmacy, telehealth features, AI documentation, and veterinary workflow.

Company-level concentration is more volatile. Full-year 2025 looked relatively distributed, with the largest deal capturing only about 14% of capital and the top 3 capturing about 39%, while YTD 2026 became highly concentrated because Lassie captured 82.5% of capital.

Investor-level fragmentation remains high. No investor appeared in more than one qualifying YTD 2026 deal, and repeat investors were limited even in 2024 and 2025.

The best description is that the Pet Tech market is consolidating around problems, not yet around a few investors or a permanent set of companies. The recurring problems are care affordability, claims friction, clinical labor, medication management, diagnostics, and health-data capture.

Where is investor attention shifting in Pet Tech?

Investor attention in the Pet Tech market is shifting toward pet healthcare infrastructure, especially software tied to insurance, payments, preventive care, diagnostics, pharmacy, veterinary operations, and AI workflow automation. The strongest evidence is that Pet Care Apps captured more than 80% of 2025 capital and more than 95% of YTD 2026 capital.

The shift is away from standalone consumer devices. Connected feeders and monitoring cameras have no qualifying rounds across the period, and hardware only appears fundable when tied to health data, AI interpretation, operating systems, or recurring engagement.

Financial infrastructure is one of the biggest investor-attention shifts. Lassie, Snout, Dalma, Napo, Pawchi, My Brown, Scooch, and Koala Health show repeated investor interest in claims, insurance, medication, payment access, preventive care, and recurring pet-health spending.

AI is also drawing attention, but the funded AI use cases are practical rather than vague. The stronger funded examples use AI for veterinary documentation, claims automation, diagnostics interpretation, behavior monitoring, health-risk detection, and workflow automation.

The Pet Tech market is therefore shifting from pet-owner convenience to pet-care economics. The companies investors appear to prefer are those that make pet care cheaper, easier, more automated, more measurable, or more financially manageable.

For a fuller view of how investor attention is shifting across Pet Tech categories, see the Pet Tech market report.

INSIGHTS

The insights below come from reviewing publicly disclosed equity rounds in the Pet Tech market between January 2024 and July 2026, with a strict focus on pure-play software and connected-device companies.

  • The Pet Tech market is becoming a healthcare-infrastructure market rather than a consumer-gadget market. The strongest funding signals are attached to insurance, financing, diagnostics, pharmacy, veterinary workflow, claims automation, and preventive care.
  • Total capital can be misleading because the market is small enough for one company to define a funding period. In YTD 2026, Lassie alone accounts for about 82.5% of all capital, so the headline funding total overstates broad market strength.
  • The 2025 funding expansion was more credible than the 2026 headline because 2025 combined more capital, more deals, and a higher median round size. YTD 2026 has a larger average round size only because of one outlier.
  • Pet Care Apps are winning because the category captures the economic layers investors care about. Claims, payments, records, clinical workflow, diagnostics, medication, and recurring care management all fit inside or adjacent to that label.
  • Connected Pet Feeders and Pet Monitoring Cameras show weak venture-market fit under a strict public equity screen. Their repeated absence does not prove weak consumer demand, but it does show weak venture-grade funding evidence.
  • First financings remain visible but financially marginal. Across 2024, 2025, and YTD 2026, first financings consistently represented a higher share of deals than dollars, which means formation continues but scaled conviction sits elsewhere.
  • The Pet Tech market is becoming more proof-driven. Larger checks are flowing to companies with recurring revenue, workflow integration, insurance economics, clinic relationships, pharmacy infrastructure, or strong health-data loops.
  • Digital pet insurance is the most important hidden subcategory. Dalma, Napo, Lassie, Pawchi, My Brown, Scooch, and related care platforms show that insurance-linked software has become one of the market’s most repeatable funding theses.
  • Tele-vet is shifting from standalone category to embedded feature. The absence of standalone YTD 2026 tele-vet deals suggests virtual vet access is becoming part of broader insurance, diagnostics, pharmacy, employer-benefit, or care-management systems.
  • Hardware is still investable only when it produces defensible data. Maven Pet, Traini, SATELLAI, and Pilton suggest that sensors, AI, health interpretation, and operating systems matter more than the physical device itself.
  • The Pet Tech market does not yet have a deep repeat-investor base. Serious investors are present, but few investors appear more than once in the strict deal list, which weakens the case for a mature specialist funding ecosystem.
  • Europe’s recent strength is real but distorted. Europe produced multiple strong 2025 companies and the largest YTD 2026 round, but its current-year capital share is mostly a Lassie effect rather than balanced regional dominance.
  • North America remains the most consistent company-formation region. It led full-year 2025 capital and continues to produce multiple qualifying companies, even though Europe dominates YTD 2026 capital through one large round.
  • Asia-Pacific is persistent but smaller-check. The region appears across the reviewed periods, but its capital share remains below its deal share, which points to earlier-stage, regional, or lower-capital-intensity activity.
  • The market’s apparent maturity depends on whether capital or deal count is weighted more heavily. Capital has moved toward later-stage companies, but deal count still includes small early experiments.
  • The lack of $50M-plus rounds in 2024 and 2025 made those years less distorted than YTD 2026. The first large megaround in the current cycle immediately made the Pet Tech market look more winner-takes-most.
  • The strongest future screening rule is whether a company owns a recurring care or payment workflow. Products connected to vets, insurers, pharmacies, clinics, diagnostics, or payment flows deserve more weight than standalone pet-parent apps.
  • AI is fundable in Pet Tech only when attached to a measurable operating problem. AI scribes, AI claims automation, AI diagnostics interpretation, and AI health monitoring are stronger than generic AI companionship or engagement claims.
  • The Pet Tech market is no longer best understood as pure consumer tech. The strongest funded companies increasingly look like vertical SaaS, insurtech, digital health, fintech, pharmacy infrastructure, or data platforms with pet-specific distribution.
  • The strict pure-player filter materially lowers the apparent size of the Pet Tech market. Including pet food, ecommerce, offline clinics, debt facilities, or broad pet services would inflate the category but blur the actual software-and-connected-device funding signal.
  • The Pet Tech market is investable but not deeply liquid. Serious investors are willing to fund strong companies, but low deal count, limited repeat-investor activity, and empty subcategories show that capital remains selective.
Sources used for this page: Every deal was checked against direct company announcements, investor announcements, press releases, tier-1 or specialist technology and pet-industry reporting, and relevant regional publications. Representative sources include PR Newswire and Business Wire announcements for companies such as MoeGo, Goose, Snout, Tandem, Petwealth, and Traini; company or investor announcements from Scribenote, Airvet, Koala Health, Digitail, Balderton, Bpifrance, and Lupa; and regional or specialist sources such as Tech.eu, EU-Startups, 36Kr, Sina Finance, WowTale, Coverager, Ahmedabad Mirror, EIN Presswire, Armilar, and GlobalPETS-style pet funding coverage. The full tracker preserves the explicit source URL for every included deal.
Chart showing how pet telehealth app technology has evolved over time

This chart, included in our Pet Tech market deck, shows how pet telehealth app technology has evolved over time

OUR METHODOLOGY TO BUILD THIS TRACKER

We built this Pet Tech funding tracker by reviewing publicly disclosed equity rounds raised by pure-play Pet Tech companies between January 2024 and July 2026. A company counts as pure-play when more than 80% of its activity is dedicated to digital products or connected devices that help people care for, monitor, train, or keep pets healthy and safe.

The tracker includes smart pet devices, pet health wearables, connected pet feeders, pet monitoring cameras, tele-vet platforms, and pet care apps when software, data, connectivity, or digital workflow is central to the product. It excludes basic pet food, toys, accessories, general online pet retail, traditional offline pet services, clinic chains whose core offer is not digital, biotech or pharma-first animal health companies, and virtual or digital pets that are not used to care for real pets.

We applied four core filters. First, only equity rounds were included, so grants, debt facilities, structured financings, acquisitions, and non-equity capital packages were excluded. Second, only rounds of $300K or more were counted. Third, undisclosed-amount rounds were excluded because including them would distort dollar-based metrics. Fourth, every included deal had to be confirmed by a direct company announcement, press release, investor announcement, tier-1 media report, specialist industry source, or relevant regional publication.

When a financing package included both equity and non-equity capital, only the disclosed equity component was counted. When a round was reported in euros, pounds, rupees, RMB, or other currencies, the amount was converted into approximate US dollars for comparability. Privately raised rounds that were never publicly announced are necessarily missing, which is a known limitation of any public-source funding tracker.

Who is the author of this content?

NEW MARKET PITCH TEAM

We track new markets so founders and investors can move faster

We build living “market pitch” documents for emerging markets: from AI to synthetic biology and new proteins. Instead of digging through outdated PDFs, random blog posts, and hallucinated LLM answers, our clients get a clean, visual, always-updated view of what’s really happening. We map the key players, deals, regulations, metrics and signals that matter so you can decide faster whether a market is worth your time. Want to know more? Check out our about page.

How we created this content 🔎📝

At New Market Pitch, we kept seeing the same problem: when you look at a new market, the data is either missing, paywalled, or buried in 300-page reports that feel like they were written in the 80s. On the other side, LLMs and random blog posts give you confident answers with no sources, and sometimes they just make things up. That’s not good enough when you’re about to invest real money or launch a company.

So we decided to fix the experience. For each market we cover, we build a structured database and update it on a regular basis. We track funding rounds, fund memos, M&A moves, partnerships, new products, policy changes, and the real activity of startups and incumbents. Then we turn all of that into a clear “market pitch” that shows where the opportunities are and how people actually win in that space.

Every key data point is checked, sourced, and put back into context by our team. That’s how we can give you both speed and reliability: fast coverage of new markets, without the usual guesswork.

Back to blog